Neutrophil-Lymphocyte Ratio As an Independent Predictor of Survival in Pulmonary Arterial Hypertension: An Exploratory Study
Overview
Authors
Affiliations
Background: The blood neutrophil-to-lymphocyte ratio (NLR) has recently emerged as a powerful predictor of adverse outcomes in some cardiovascular and lung diseases. Pulmonary arterial hypertension (PAH) is a lethal vasculopathy associated with increased inflammation. Although PAH exhibits a higher prevalence among women, men have a poorer prognosis. We investigated the NLR as an independent predictor of transplant-free survival in PAH.
Methods: We performed a retrospective analysis of 78 PAH patients from the Quebec PAHBiobank (71% female). We used univariate and multivariate (adjusted for age, sex, renal function, and disease severity) Cox regression analyses to assess the relationship between the NLR and transplant-free survival, in the whole sample, and according to sex. The NLR was categorized as high (≥ 4.8) or low (< 4.8) using receiver operating characteristic analysis. Unadjusted Kaplan-Meier analysis estimated survival per NLR category.
Results: The NLR was higher in patients who died, compared to that in patients who had transplant-free survival ( < 0.05). The NLR was an independent predictor of event-free survival in PAH (unadjusted hazard ratio: 1.11, 95% confidence interval: 1.04-1.18, which remained significant after adjustment for covariates). The high-NLR group had lower 1-, 3-, and 5-year survival compared to those with a low NLR ( < 0.001). The NLR remains a predictor of survival in women.
Conclusions: The NLR is an independent predictor of transplant-free survival in PAH. We report a potential sexual dimorphism in the ability of the NLR to predict mortality in PAH, emphasizing the importance of considering sex-related differences in the development of biomarkers in PAH.
Ge H, Zhang L, Zhang W, Yuan Q, Xiao X Medicine (Baltimore). 2024; 103(44):e40161.
PMID: 39496051 PMC: 11537574. DOI: 10.1097/MD.0000000000040161.
Dong H, Wang F, Gao L, Xu X, Ni Y BMJ Open. 2024; 14(9):e083227.
PMID: 39242162 PMC: 11381719. DOI: 10.1136/bmjopen-2023-083227.
Topyla-Putowska W, Tomaszewski M, Wojtkowska A, Wysokinski A J Pers Med. 2023; 13(12).
PMID: 38138854 PMC: 10744346. DOI: 10.3390/jpm13121627.
Jiang T, Wang Q, Zhang Z, Qi J, Yang Z, Jiang Q J Int Med Res. 2023; 51(9):3000605231200266.
PMID: 37740646 PMC: 10517620. DOI: 10.1177/03000605231200266.
Biomarkers in Pulmonary Arterial Hypertension.
Hojda S, Chis I, Clichici S Diagnostics (Basel). 2022; 12(12).
PMID: 36553040 PMC: 9776459. DOI: 10.3390/diagnostics12123033.